$VRAYQ
ViewRay Inc

2021 Q2 Form 10-Q Financial Statement

#000156459021041871 Filed on August 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $15.03M $14.22M
YoY Change 5.67% -52.85%
Cost Of Revenue $16.70M $15.27M
YoY Change 9.38% -43.28%
Gross Profit -$1.672M -$1.040M
YoY Change 60.77% -132.04%
Gross Profit Margin -11.12% -7.31%
Selling, General & Admin $16.91M $18.32M
YoY Change -7.7% -20.56%
% of Gross Profit
Research & Development $7.903M $6.210M
YoY Change 27.26% -3.91%
% of Gross Profit
Depreciation & Amortization $1.600M $1.500M
YoY Change 6.67% 36.36%
% of Gross Profit
Operating Expenses $24.81M $24.53M
YoY Change 1.15% -16.92%
Operating Profit -$26.49M -$25.57M
YoY Change 3.58% -2.69%
Interest Expense $1.060M -$980.0K
YoY Change -208.16% -191.25%
% of Operating Profit
Other Income/Expense, Net -$3.434M $410.0K
YoY Change -937.56% -109.92%
Pretax Income -$30.98M -$26.15M
YoY Change 18.46% -15.1%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$30.98M -$26.15M
YoY Change 18.45% -15.09%
Net Earnings / Revenue -206.09% -183.86%
Basic Earnings Per Share -$0.19
Diluted Earnings Per Share -$0.19 -$177.2K
COMMON SHARES
Basic Shares Outstanding 162.2M shares
Diluted Shares Outstanding 162.2M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $166.9M $179.5M
YoY Change -7.01% 47.01%
Cash & Equivalents $166.9M $179.5M
Short-Term Investments
Other Short-Term Assets $6.300M $11.90M
YoY Change -47.06% 10.19%
Inventory $45.56M $48.20M
Prepaid Expenses
Receivables $15.42M $22.09M
Other Receivables $0.00 $0.00
Total Short-Term Assets $234.2M $266.3M
YoY Change -12.05% 14.76%
LONG-TERM ASSETS
Property, Plant & Equipment $21.75M $22.72M
YoY Change -4.24% 3.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.852M $1.642M
YoY Change 439.1% -4.37%
Total Long-Term Assets $39.67M $36.89M
YoY Change 7.53% -2.69%
TOTAL ASSETS
Total Short-Term Assets $234.2M $266.3M
Total Long-Term Assets $39.67M $36.89M
Total Assets $273.9M $303.2M
YoY Change -9.67% 12.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.525M $4.852M
YoY Change 55.09% -74.78%
Accrued Expenses $18.30M $17.36M
YoY Change 5.43% -8.19%
Deferred Revenue $11.04M $16.79M
YoY Change -34.23% 103.94%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $10.89M
YoY Change
Total Short-Term Liabilities $52.99M $68.30M
YoY Change -22.41% 17.92%
LONG-TERM LIABILITIES
Long-Term Debt $57.10M $44.80M
YoY Change 27.46% -19.2%
Other Long-Term Liabilities $2.513M $1.680M
YoY Change 49.58% 289.79%
Total Long-Term Liabilities $59.61M $1.680M
YoY Change 3448.45% -96.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.99M $68.30M
Total Long-Term Liabilities $59.61M $1.680M
Total Liabilities $134.8M $129.2M
YoY Change 4.35% -12.12%
SHAREHOLDERS EQUITY
Retained Earnings -$684.8M -$572.9M
YoY Change 19.54% 23.69%
Common Stock $823.9M $746.9M
YoY Change 10.31% 27.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $139.1M $174.0M
YoY Change
Total Liabilities & Shareholders Equity $273.9M $303.2M
YoY Change -9.67% 12.31%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$30.98M -$26.15M
YoY Change 18.45% -15.09%
Depreciation, Depletion And Amortization $1.600M $1.500M
YoY Change 6.67% 36.36%
Cash From Operating Activities -$14.00M -$10.02M
YoY Change 39.74% -61.31%
INVESTING ACTIVITIES
Capital Expenditures -$228.0K -$850.0K
YoY Change -73.18% -72.58%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$228.0K -$850.0K
YoY Change -73.18% -72.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -855.0K 170.0K
YoY Change -602.94% -96.8%
NET CHANGE
Cash From Operating Activities -14.00M -10.02M
Cash From Investing Activities -228.0K -850.0K
Cash From Financing Activities -855.0K 170.0K
Net Change In Cash -15.08M -10.70M
YoY Change 40.98% -54.81%
FREE CASH FLOW
Cash From Operating Activities -$14.00M -$10.02M
Capital Expenditures -$228.0K -$850.0K
Free Cash Flow -$13.77M -$9.170M
YoY Change 50.21% -59.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2286000
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2181000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11041000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
52991000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4962000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
57101000
CY2021Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
9212000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8039000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2513000
CY2021Q2 us-gaap Liabilities
Liabilities
134818000
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1624000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
822230000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-684803000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
139051000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
273869000
CY2021Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-1473000
CY2021Q1 vray Adjustments To Additional Paid In Capital Stock Issued Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOfferingCosts
3991000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4701000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4763000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2957000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6684000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
1595000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-1814000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
12232000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40312000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
568000
CY2021Q1 vray Stock Issued During Period Value Warrant Exercises
StockIssuedDuringPeriodValueWarrantExercises
2000
CY2021Q1 vray Adjustments To Additional Paid In Capital Warrant Exercises
AdjustmentsToAdditionalPaidInCapitalWarrantExercises
327000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26743000
CY2021Q2 vray Adjustments To Additional Paid In Capital Warrant Exercises
AdjustmentsToAdditionalPaidInCapitalWarrantExercises
24000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
264000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
216174000
CY2020Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-131000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-27532000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5802000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
156000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-26152000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
174024000
us-gaap Net Income Loss
NetIncomeLoss
-57719000
us-gaap Net Income Loss
NetIncomeLoss
-53684000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-12000
us-gaap Inventory Write Down
InventoryWriteDown
0
us-gaap Inventory Write Down
InventoryWriteDown
150000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
471000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
357000
vray Product Upgrade Reserve
ProductUpgradeReserve
1000000
vray Product Upgrade Reserve
ProductUpgradeReserve
-1260000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3647000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5272000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-755000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
4390000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5397000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2327000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2508000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8470000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1865000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2057000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45018000
vray Fair Value Of Common Stock Warrants Reclassed From Liability To Additional Paid In Capital Upon Exercise
FairValueOfCommonStockWarrantsReclassedFromLiabilityToAdditionalPaidInCapitalUponExercise
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
vray Property And Equipment Transferred From Inventory And Deferred Cost Of Revenue
PropertyAndEquipmentTransferredFromInventoryAndDeferredCostOfRevenue
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-568000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1295000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
184000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
264000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
156000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2759000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
132000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51085000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-500000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10205000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46813000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
158180000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
228187000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168385000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
181374000
us-gaap Interest Paid Net
InterestPaidNet
1648000
us-gaap Interest Paid Net
InterestPaidNet
2140000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
28000
vray Fair Value Of Common Stock Warrants Reclassed From Liability To Additional Paid In Capital Upon Exercise
FairValueOfCommonStockWarrantsReclassedFromLiabilityToAdditionalPaidInCapitalUponExercise
351000
vray Property And Equipment Transferred From Inventory And Deferred Cost Of Revenue
PropertyAndEquipmentTransferredFromInventoryAndDeferredCostOfRevenue
1583000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
351000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
65000
us-gaap Net Income Loss
NetIncomeLoss
-57700000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40300000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166900000
CY2020Q4 vray Accrued Product Upgrade Reserve Current
AccruedProductUpgradeReserveCurrent
1500000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1333000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
458000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18304000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19281000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53249000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52563000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31495000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28501000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21754000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24062000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1600000
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1500000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3200000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3000000.0
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8963000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12810000
CY2021Q2 vray Accrued Payable
AccruedPayable
3964000
CY2020Q4 vray Accrued Payable
AccruedPayable
2810000
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1332000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1398000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
212000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
305000
CY2021Q2 vray Accrued Product Upgrade Reserve Current
AccruedProductUpgradeReserveCurrent
2500000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16003000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
12666000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11041000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10094000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4962000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2572000
CY2020Q4 vray Accrued Interest Noncurrent
AccruedInterestNoncurrent
99000
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
9212000
CY2021Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
918000
CY2020Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
857000
CY2021Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
1187000
CY2020Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
0
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2513000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
956000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4864000
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5373000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-4701000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3301000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1730000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9977000
vray Long Term Trade Credit Maintenance Services Term
LongTermTradeCreditMaintenanceServicesTerm
P1Y
CY2019Q3 vray Number Of Patents Infringes
NumberOfPatentsInfringes
2
CY2021Q2 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
6000000.0
us-gaap Operating Lease Cost
OperatingLeaseCost
1509000
us-gaap Operating Lease Cost
OperatingLeaseCost
1562000
us-gaap Operating Lease Payments
OperatingLeasePayments
1554000
us-gaap Operating Lease Payments
OperatingLeasePayments
1567000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1293000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2659000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2738000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2774000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2096000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
147000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11707000
CY2021Q2 us-gaap Purchase Obligation
PurchaseObligation
5000000.0
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15030000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14224000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30555000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28474000
CY2020Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
100000
CY2021Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3200000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6600000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2700000
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2100000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6900000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5400000
CY2021Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7418204
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.97
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7905000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.94
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5559000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
680493
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.20
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
7573000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
vray Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
119420
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2036733
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6455000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5803000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14949000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11304000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8142348
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.14
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2638000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43651
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.26
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5452385
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
7260596
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.20
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.688
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3000000.0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2700000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18410141
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18410141
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22722094
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22722094
CY2021Q2 vray Percentage Of Royalty Expense Based On Net Sales
PercentageOfRoyaltyExpenseBasedOnNetSales
0.01
CY2020Q2 vray Percentage Of Royalty Expense Based On Net Sales
PercentageOfRoyaltyExpenseBasedOnNetSales
0.01
CY2021Q2 vray Percentage Of Royalty Expense Based On Net Sales
PercentageOfRoyaltyExpenseBasedOnNetSales
0.01
CY2020Q2 vray Percentage Of Royalty Expense Based On Net Sales
PercentageOfRoyaltyExpenseBasedOnNetSales
0.01

Files In Submission

Name View Source Status
0001564590-21-041871-index-headers.html Edgar Link pending
0001564590-21-041871-index.html Edgar Link pending
0001564590-21-041871.txt Edgar Link pending
0001564590-21-041871-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gqxmpzwfojdw000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vray-10q_20210630.htm Edgar Link pending
vray-10q_20210630_htm.xml Edgar Link completed
vray-20210630.xsd Edgar Link pending
vray-20210630_cal.xml Edgar Link unprocessable
vray-20210630_def.xml Edgar Link unprocessable
vray-20210630_lab.xml Edgar Link unprocessable
vray-20210630_pre.xml Edgar Link unprocessable
vray-ex311_7.htm Edgar Link pending
vray-ex312_8.htm Edgar Link pending
vray-ex321_6.htm Edgar Link pending